Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Cv Sciences Inc
(OP:
CVSI
)
0.6250
USD
-0.0050 (-0.79%)
Official Closing Price
Updated: 3:59 PM EST, Jan 15, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Cv Sciences Inc
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
CV Sciences, Inc. Announces Launch of ProCBD™ Product Line
January 05, 2021
Clinical Strength ProCBD™ is Supported by Clinical Research and Available Exclusively Through Health Practitioners
From
GlobeNewswire News Releases
CV Sciences, Inc. Receives Nutritional Outlook’s 2020 Best of the Industry Award
December 10, 2020
From
GlobeNewswire News Releases
CV Sciences, Inc. Announces Closing of Committed Equity Financing Transaction
December 08, 2020
From
GlobeNewswire News Releases
CV Sciences, Inc. Reports Third Quarter 2020 Financial Results
November 05, 2020
From
GlobeNewswire News Releases
CV Sciences, Inc. Announces Launch of PlusCBD™ Pet Product Line
November 04, 2020
Full line of soothing hemp extracts formulated exclusively for dogs and cats
From
GlobeNewswire News Releases
CV Sciences, Inc. to Announce Third Quarter 2020 Results on November 5, 2020
October 23, 2020
From
GlobeNewswire News Releases
CV Sciences, Inc. Announces PlusCBD™ Brand Refresh and New Product Launches
October 06, 2020
PlusCBD™ refresh reflects the brand’s core mission to improve quality of life through nature and science
From
GlobeNewswire News Releases
CV Sciences, Inc. Announces Launch of CV™ Defense Daily Immune Support
September 10, 2020
CV™ Defense now available on CV Sciences website and launching on Amazon.com next week
From
GlobeNewswire News Releases
Market For CBD Infused Products Could Surpass $20 Billion By 2024
September 10, 2020
Financialnewsmedia.com News Commentary
From
PR Newswire
Market For CBD Infused Products Could Surpass $20 Billion By 2024
September 10, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
CV Sciences, Inc. Launches New Website Reflecting Core Values and Mission of Improving Quality of Life Through Nature and Science
September 02, 2020
From
GlobeNewswire News Releases
CV Sciences, Inc. to Participate in Alliance Global Partners Virtual Event
August 20, 2020
From
GlobeNewswire News Releases
CV Sciences, Inc. Experts Contribute to Journal of Dietary Supplements First Special Issue on Cannabinoids
August 13, 2020
From
GlobeNewswire News Releases
CV Sciences, Inc. Reports Second Quarter 2020 Financial Results
August 06, 2020
From
GlobeNewswire News Releases
Consumer CBD, CBG, CBN Based Products Expected to Continue to Grow at a Substantial Pace
August 06, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Consumer CBD, CBG, CBN Based Products Expected to Continue to Grow at a Substantial Pace
August 06, 2020
Financialnewsmedia.com News Commentary
From
PR Newswire
CV Sciences, Inc. Announces Launch of Happy Lane™ CBD Product Line
August 05, 2020
THC-free Happy Lane™ expands CV Sciences’ sales channels and consumer access to safe and effective CBD
From
GlobeNewswire News Releases
CV Sciences, Inc. Announces Expansion with the Launch of CV™ Acute and New Immunity Product Line
July 29, 2020
Clinically researched wide spectrum proprietary plant-based formula supports immune system and respiratory health
From
GlobeNewswire News Releases
CV Sciences, Inc. to Announce Second Quarter 2020 Results on August 6, 2020
July 23, 2020
From
GlobeNewswire News Releases
While FDA Advances Work Related to Cannabidiol Products CBD Usage Rates Are On The Rise
June 30, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
While FDA Advances Work Related to Cannabidiol Products CBD Usage Rates are on the Rise
June 30, 2020
Financialnewsmedia.com News Commentary
From
PR Newswire
Rise in CBD and CBG's Popularity Driven By Combination of Non-psychoactive Nature and Therapeutic Properties
June 23, 2020
Financialnewsmedia.com News Commentary
From
PR Newswire
Rise In CBD and CBG’s Popularity Driven By Combination Of Non-Psychoactive Nature and Therapeutic Properties
June 23, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
CV Sciences, Inc. Announces Publication of Two Research Studies Demonstrating the Safety and Health Benefits of PlusCBD™ Products
June 02, 2020
From
GlobeNewswire News Releases
CBD Infused Beverages Market Size Expected To Reach $2.8 Billion By 2025
May 27, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
CBD Infused Beverages Market Size Expected to Reach $2.8 Billion by 2025
May 27, 2020
Financialnewsmedia.com News Commentary
From
PR Newswire
CV Sciences, Inc. Announces Plan to Adjourn Annual Meeting of Stockholders to June 16, 2020
May 20, 2020
From
GlobeNewswire News Releases
CV Sciences, Inc. Receives Formal Notice of Patent Issuance from USPTO for Proprietary Cannabidiol (CBD) and Nicotine Formulation for Treating Smokeless Tobacco Addiction
May 20, 2020
Formal Issuance of a U.S. Patent Strengthens Drug Development Business and Provides Valuable Intellectual Property to Address Large Unmet Market Opportunity
From
GlobeNewswire News Releases
CV Sciences, Inc. Reports First Quarter 2020 Financial Results
May 08, 2020
From
GlobeNewswire News Releases
Governments Around the World Show Support for Medical Cannabis
May 07, 2020
FinancialBuzz.com News Commentary
From
PR Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.